发明名称 USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE
摘要 An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).
申请公布号 US2015079055(A1) 申请公布日期 2015.03.19
申请号 US201414493637 申请日期 2014.09.23
申请人 Children's Hospital Medical Center ;The General Hospital Corporation ;Instituto Nacional de Ciencias Medicas Y Nutricion 发明人 Morrow Ardythe L.;Newburg David S.;Ruiz-Palacios Guillermo M.
分类号 A61K31/7028;A61K38/02;A61K45/06;A61K31/702 主分类号 A61K31/7028
代理机构 代理人
主权项
地址 Cincinnati OH US